Early diagnosis and treatment of NMOSD: Practical insights

touchCONGRESS for touchHAEMATOLOGY Listen to immune thrombocytopenia (ITP) expert Dr Vickie McDonald review key data presented at the European Hematology Association (EHA) and International Society on Thrombosis and Haemostasis (ISTH) 2024 congresses on the impact and current and future management of ITP. She is joined by two additional leading ITP experts, Prof. James Bussel and Prof. Waleed Ghanima, to discuss how these data may apply in clinical practice. Overview  Data reviews with Dr McDonald Expert panel discussions with Dr McDonald, Prof. Bussel and Prof. Ghanima on the themes below Clinical themes How does ITP impact the patient and their quality of life? What are the latest data that inform the use of current treatments for chronic ITP? What data are there for emerging chronic ITP treatments and what do they tell us? The internationally renowned RCC expert faculty Dr Vickie McDonald: London, UK Prof. James Bussel: New York, NY, USA, Prof. Waleed Ghanima: Oslo, Norway This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals, Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:  www.touchHAEMATOLOGY.com

touchCONGRESS for touchONCOLOGY Listen to immune thrombocytopenia (ITP) expert Dr Vickie McDonald review key data presented at the European Hematology Association (EHA) and International Society on Thrombosis and Haemostasis (ISTH) 2024 congresses on the impact and current and future management of ITP. She is joined by two additional leading ITP experts, Prof. James Bussel and Prof. Waleed Ghanima, to discuss how these data may apply in clinical practice. Overview  Data reviews with Dr McDonald Expert panel discussions with Dr McDonald, Prof. Bussel and Prof. Ghanima on the themes below Clinical themes How does ITP impact the patient and their quality of life? What are the latest data that inform the use of current treatments for chronic ITP? What data are there for emerging chronic ITP treatments and what do they tell us? The internationally renowned RCC expert faculty Dr Vickie McDonald: London, UK Prof. James Bussel: New York, NY, USA, Prof. Waleed Ghanima: Oslo, Norway This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals, Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:  www.touchONCOLOGY.com

touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a panel of experts discuss the benefits of CGM in patients with T2D, strategies to overcome the barriers to its uptake and how to best support patients in implementing CGM. The experts Prof. Stewart Harris, Western University,  London, Ontario, Canada, Dr Anders Carlson, International Diabetes Center at Park Nicollet, Minneapolis, MN, USA, Prof. Shannon Idzik, University of Maryland School of Nursing, Baltimore, MD, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:  www.touchENDOCRINOLOGY.com 

touchFOCUS for touchONCOLOGY Listen to Prof. Hans Hammers as he answers a series of questions on the application of prognostic markers and clinical data within the multidisciplinary team to personalize care for patients with early stage through to advanced and metastatic RCC. In addition, he responds to questions on the use of effective communication strategies and shared decision-making when managing diverse and/or underserved populations with RCC. The expert Prof. Hans Hammers, UT Southwestern, Dallas, TX, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/personalizing-care-multidisciplinary-team-renal-cell-carcinoma/

touchIN CONVERSATION for touchINFECTIOUS DISEASES Listen to a conversation between Dr Christoph Boesecke and Dr Tristan Barber, two experts on HIV practising in Germany and the UK. They respond to questions submitted by the HCP audience and provide their insights on best practices for antiretroviral therapy selection for people living with HIV. The experts Dr Christoph Boesecke – University of Bonn, Bonn, Germany Dr Tristan Barber – Royal Free London NHS Foundation Trust, London, UK This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical educational grant from ViiV Healthcare. This activity is provided by touchIME. For further information visit our website: https://touchinfectiousdiseases.com/education/hiv-art-selection-shared-decision-making/      

touchPANEL DISCUSSION for touchOPHTHALMOLOGY Listen to a panel of leading experts discuss thyroid eye disease, including the underlying mechanisms, risk factors, symptomatology and burden of disease in affected patients, as well as the process for screening and diagnosing the disease. The experts Dr Andrea Kossler, Stanford University School of Medicine, Palo Alto, CA, USA Dr Mario Salvi, University of Milan, Milan, Italy Dr Edsel Ing, University of Alberta, Edmonton and University of Toronto, Ontario, Canada This touchPODCAST is for HCPs only.  This activity is funded by an independent medical education grant from Horizon Therapeutics and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit: https://touchophthalmologyime.org/thyroid-eye-disease-an-evolving-continuum-of-care/

touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a panel of leading experts discuss thyroid eye disease, including the underlying mechanisms, risk factors, symptomatology and burden of disease in affected patients, as well as the process for screening and diagnosing the disease.  The experts Dr Andrea Kossler, Stanford University School of Medicine, Palo Alto, CA, USA Dr Mario Salvi, University of Milan, Milan, Italy Dr Edsel Ing, University of Alberta, Edmonton and University of Toronto, Ontario, Canada This touchPODCAST is for HCPs only.  This activity is funded by an independent medical education grant from Horizon Therapeutics and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit: https://touchendocrinologyime.org/thyroid-eye-disease-an-evolving-continuum-of-care/    

touchTALKS for touchNEUROLOGY A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition.  The expert Prof. Dr. med. Jan Beyer-Westendorf, University Hospital Carl Gustav Carus, Dresden, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchneurology.com

touchTALKS for touchCARDIO A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition.  The expert Prof. Dr. med. Jan Beyer-Westendorf, University Hospital Carl Gustav Carus, Dresden, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchCARDIO.com 

touchFOCUS for touchONCOLOGY   Listen to Dr Dana Chase discuss the role of HER2 as a pan-tumour biomarker and the implications for treatment across various cancer types. The expert Dr Dana Chase - UCLA Health, Los Angeles, CA, USA   This touchPODCAST is for HCPs only.   This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.    For further information visit our website: https://touchoncologyime.org/